跳转至内容
Merck

K3502

Sigma-Aldrich

抗 人 κ 轻链(结合和游离) 山羊抗

affinity isolated antibody, lyophilized powder

登录查看公司和协议定价


About This Item

MDL號碼:
分類程式碼代碼:
12352203
NACRES:
NA.46

生物源

goat

品質等級

共軛

unconjugated

抗體表格

affinity isolated antibody

抗體產品種類

secondary antibodies

無性繁殖

polyclonal

形狀

lyophilized powder

技術

quantitative precipitin assay: suitable

儲存溫度

2-8°C

目標翻譯後修改

unmodified

基因資訊

human ... IGK@(50802)

正在寻找类似产品? 访问 产品对比指南

一般說明

抗人 κ轻链(结合和游离)抗体获自山羊抗血清。免疫特异性纯化去除所有不与 κ轻链(结合和游离)。抗体制备对 κ对照结合和游离轻链检测时的轻链。产物不与结合或游离 λ 反应轻链。

免疫原

纯化的人正常和骨髓瘤 κ轻链

應用

基于玉米种子提取物进行ELISA 时(工作抗体稀释度1:200),抗人κ轻链(结合和游离)-FITC 抗体用作二抗。使用NSO/1骨髓瘤细胞、HEK293细胞和小鼠血浆进行ELISA时,使用1-2 μg/ml的抗体浓度。制备抗莠去津免疫传感器时,该抗体还用于包被电极表面。
山羊抗人κ轻链(结合和游离态)抗体可用于蛋白质免疫印迹。

外觀

从 0.01 M 磷酸钠、0.015 M 氯化钠 (pH 7.2) 冻干

重構

用 0.135 M 氯化钠复溶。

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

Not finding the right product?  

Try our 产品选型工具.


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Eva Gschmack et al.
Journal of neural transmission (Vienna, Austria : 1996), 129(5-6), 545-555 (2022-04-03)
Idiopathic Parkinson's disease (PD) is characterized by a progredient degeneration of the brain, starting at deep subcortical areas such as the dorsal motor nucleus of the glossopharyngeal and vagal nerves (DM) (stage 1), followed by the coeruleus-subcoeruleus complex; (stage 2)
Characterization of immunological interactions at an immunoelectrode by scanning electron microscopy
Ambrosi A et al
Electroanalysis, 19, 244-252 (2007)
Yvonne J Rosenberg et al.
PloS one, 11(3), e0152760-e0152760 (2016-04-01)
Intravascular delivery of broadly neutralizing antibodies (bnAbs) has shown promise for prevention and treatment of HIV infection. However, multiple IV administrations in geographic locations with poor accessibility to medical care have practical limitations. We have assessed the efficacy of plant-derived
Koreen Ramessar et al.
Proceedings of the National Academy of Sciences of the United States of America, 105(10), 3727-3732 (2008-03-05)
A series of small-molecule microbicides has been developed for vaginal delivery to prevent heterosexual HIV transmission, but results from human clinical trials have been disappointing. Protein-based microbicides, such as HIV-specific monoclonal antibodies, have been considered as an alternative approach. Despite
Sven Mathias et al.
Biotechnology and bioengineering, 117(1), 5-16 (2019-10-22)
Although most therapeutic monoclonal antibodies (mAbs) can routinely be produced in the multigram per litre range, some mAb candidates turn out to be difficult-to-express (DTE). In addition, the class of more complex biological formats is permanently increasing and mammalian expression

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门